1621 |
100 µg |
N-Hexanoyl-NBD-galactosylceramide |
N-C6:0-NBD-beta-D-galactosylsphingosine; N-C6:0-NBD-cerebroside; N-C6:0-NBD-galactosylceramide, fluorescent |
1622 |
100 µg |
N-Hexanoyl-NBD-glucosylceramide |
N-C6:0-NBD-beta-D-glucosylsphingosine; N-C6:0-NBD-glucosylceramide |
1622-001 |
1 mg |
N-Hexanoyl-NBD-glucosylceramide |
N-C6:0-NBD-beta-D-glucosylsphingosine; N-C6:0-NBD-glucosylceramide |
1629 |
50 µg |
N-Hexanoyl-NBD-lactosylceramide |
N-C6:0-NBD-lactosylceramide; N-Hexanoyl-NBD-beta-D-lactosylsphingosine |
1629-001 |
1 mg |
N-Hexanoyl-NBD-lactosylceramide |
N-C6:0-NBD-lactosylceramide; N-Hexanoyl-NBD-beta-D-lactosylsphingosine |
1630 |
50 µg |
N-Dodecanoyl-NBD-lactosylceramide |
N-C12:0-NBD-lactosylceramide; N-Dodecanoyl-NBD-beta-D-lactosylsphingosine; fluorescent LC |
1630-001 |
1 mg |
N-Dodecanoyl-NBD-lactosylceramide |
N-C12:0-NBD-lactosylceramide; N-Dodecanoyl-NBD-beta-D-lactosylsphingosine; fluorescent LC |
1631 |
100 µg |
N-Dodecanoyl-NBD-ceramide trihexoside |
N-C12:0-NBD-globotriaosylceramide; N-C12:0-NBD-CTH |
1631-001 |
1 mg |
N-Dodecanoyl-NBD-ceramide trihexoside |
N-C12:0-NBD-globotriaosylceramide; N-C12:0-NBD-CTH |
1632 |
100 µg |
N-Dodecanoyl-NBD-sulfatide |
N-C12:0-NBD-sulfatide; N-Dodecanoyl-NBD-lyso-sulfatide; N-Dodecanoyl-NBD-sphingosyl-beta-D-galactoside-3-sulfate |
1632-001 |
1 mg |
N-Dodecanoyl-NBD-sulfatide |
N-C12:0-NBD-sulfatide; N-Dodecanoyl-NBD-lyso-sulfatide; N-Dodecanoyl-NBD-sphingosyl-beta-D-galactoside-3-sulfate |
1633 |
100 µg |
N-Dodecanoyl-NBD-galactosylceramide |
N-C12:0-NBD-beta-D-Galactosylsphingosine; N-C12:0-NBD-Cerebrosidee |
1633-001 |
1 mg |
N-Dodecanoyl-NBD-galactosylceramide |
N-C12:0-NBD-beta-D-Galactosylsphingosine; N-C12:0-NBD-Cerebrosidee |